Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1024069417 | 10240694 | 17 | F | 20101019 | 20160616 | 20140617 | 20160630 | EXP | US-ACORDA-ACO_26425_2011 | ACORDA | 84.51 | YR | F | Y | 57.60000 | KG | 20160630 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1024069417 | 10240694 | 1 | PS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, Q 12 HRS | 22250 | 10 | MG | TABLET | Q12H | ||||||
1024069417 | 10240694 | 2 | SS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, QD | 22250 | 10 | MG | TABLET | QD | ||||||
1024069417 | 10240694 | 3 | SS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, BID | 22250 | 10 | MG | TABLET | BID | ||||||
1024069417 | 10240694 | 4 | SS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, QD | 22250 | 10 | MG | TABLET | QD | ||||||
1024069417 | 10240694 | 5 | SS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, BID | 22250 | 10 | MG | TABLET | BID | ||||||
1024069417 | 10240694 | 6 | SS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, BID | 22250 | 10 | MG | TABLET | Q12H | ||||||
1024069417 | 10240694 | 7 | SS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, BID | 22250 | 10 | MG | TABLET | BID | ||||||
1024069417 | 10240694 | 8 | SS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, BID | 22250 | 10 | MG | TABLET | BID | ||||||
1024069417 | 10240694 | 9 | SS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, QD | 22250 | 10 | MG | TABLET | QD | ||||||
1024069417 | 10240694 | 10 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 112 ?G, QD | U | 0 | 112 | UG | QD | ||||||
1024069417 | 10240694 | 11 | C | BACLOFEN. | BACLOFEN | 1 | Oral | 10 MG, BID | U | 0 | 10 | MG | BID | ||||||
1024069417 | 10240694 | 12 | C | LASIX | FUROSEMIDE | 1 | U | 0 | |||||||||||
1024069417 | 10240694 | 13 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Unknown | 1000 ?G, QD | U | 0 | 1000 | UG | QD | ||||||
1024069417 | 10240694 | 14 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Unknown | 500 ?G, UNK | U | 0 | 500 | UG | |||||||
1024069417 | 10240694 | 15 | C | CALTRATE WITH VITAMIN D | CALCIUM CARBONATECHOLECALCIFEROL | 1 | 1 DF, QD | U | 0 | 1 | DF | QD | |||||||
1024069417 | 10240694 | 16 | C | Centrum silver | MINERALSVITAMINS | 1 | UNK | U | 0 | ||||||||||
1024069417 | 10240694 | 17 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Unknown | 5000 UNK, UNK | U | 0 | 5000 | IU | |||||||
1024069417 | 10240694 | 18 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Unknown | 1000 IU, UNK | U | 0 | 1000 | IU | |||||||
1024069417 | 10240694 | 19 | C | Potassium | POTASSIUM | 1 | UNK | U | 0 | ||||||||||
1024069417 | 10240694 | 20 | C | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | Unknown | 115 ?G, UNK | U | 0 | 115 | UG | |||||||
1024069417 | 10240694 | 21 | C | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | 112 ?G, UNK | U | 0 | 112 | UG | ||||||||
1024069417 | 10240694 | 22 | C | ECOTRIN | ASPIRIN | 1 | 325 MG, UNK | U | 0 | 325 | MG | ||||||||
1024069417 | 10240694 | 23 | C | ECOTRIN | ASPIRIN | 1 | Unknown | 81 MG, UNK | U | 0 | 81 | MG | |||||||
1024069417 | 10240694 | 24 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 325 MG, QD | U | 0 | 325 | MG | QD | ||||||
1024069417 | 10240694 | 25 | C | DITROPAN XL | OXYBUTYNIN CHLORIDE | 1 | Unknown | 5MG, 1 TAB QD | U | 0 | |||||||||
1024069417 | 10240694 | 26 | C | LEVOTHROID | LEVOTHYROXINE SODIUM | 1 | Unknown | 113 ?G, UNK | U | 0 | 113 | UG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
1024069417 | 10240694 | 1 | Gait disturbance |
1024069417 | 10240694 | 2 | Asthenia |
1024069417 | 10240694 | 3 | Dysstasia |
1024069417 | 10240694 | 4 | Asthenia |
1024069417 | 10240694 | 10 | Product used for unknown indication |
1024069417 | 10240694 | 11 | Muscle spasms |
1024069417 | 10240694 | 12 | Product used for unknown indication |
1024069417 | 10240694 | 13 | Product used for unknown indication |
1024069417 | 10240694 | 15 | Product used for unknown indication |
1024069417 | 10240694 | 16 | Product used for unknown indication |
1024069417 | 10240694 | 17 | Product used for unknown indication |
1024069417 | 10240694 | 19 | Product used for unknown indication |
1024069417 | 10240694 | 20 | Product used for unknown indication |
1024069417 | 10240694 | 22 | Product used for unknown indication |
1024069417 | 10240694 | 24 | Product used for unknown indication |
1024069417 | 10240694 | 25 | Product used for unknown indication |
1024069417 | 10240694 | 26 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
1024069417 | 10240694 | OT |
1024069417 | 10240694 | HO |
1024069417 | 10240694 | DS |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
1024069417 | 10240694 | Asthenia | |
1024069417 | 10240694 | Back pain | |
1024069417 | 10240694 | Bedridden | |
1024069417 | 10240694 | Burning sensation | |
1024069417 | 10240694 | Compression fracture | |
1024069417 | 10240694 | Constipation | |
1024069417 | 10240694 | Cough | |
1024069417 | 10240694 | Cystitis | |
1024069417 | 10240694 | Cystitis klebsiella | |
1024069417 | 10240694 | Depression | |
1024069417 | 10240694 | Dyskinesia | |
1024069417 | 10240694 | Dysstasia | |
1024069417 | 10240694 | Escherichia infection | |
1024069417 | 10240694 | Gastrooesophageal reflux disease | |
1024069417 | 10240694 | Headache | |
1024069417 | 10240694 | Hypoaesthesia | |
1024069417 | 10240694 | Inappropriate schedule of drug administration | |
1024069417 | 10240694 | Insomnia | |
1024069417 | 10240694 | Joint contracture | |
1024069417 | 10240694 | Kidney infection | |
1024069417 | 10240694 | Lower limb fracture | |
1024069417 | 10240694 | Lumbar spinal stenosis | |
1024069417 | 10240694 | Muscle spasms | |
1024069417 | 10240694 | Muscular weakness | |
1024069417 | 10240694 | Nephrolithiasis | |
1024069417 | 10240694 | Oedema | |
1024069417 | 10240694 | Off label use | |
1024069417 | 10240694 | Osteoporosis | |
1024069417 | 10240694 | Pain in extremity | |
1024069417 | 10240694 | Paraesthesia | |
1024069417 | 10240694 | Paranoia | |
1024069417 | 10240694 | Pruritus | |
1024069417 | 10240694 | Pruritus generalised | |
1024069417 | 10240694 | Psychotic disorder | |
1024069417 | 10240694 | Pulmonary embolism | |
1024069417 | 10240694 | Sepsis | |
1024069417 | 10240694 | Spinal fracture | |
1024069417 | 10240694 | Stress fracture | |
1024069417 | 10240694 | Therapeutic response unexpected | |
1024069417 | 10240694 | Therapy cessation | |
1024069417 | 10240694 | Urethral disorder | |
1024069417 | 10240694 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
1024069417 | 10240694 | 1 | 20100712 | 0 | ||
1024069417 | 10240694 | 2 | 20110608 | 0 | ||
1024069417 | 10240694 | 4 | 20120926 | 0 | ||
1024069417 | 10240694 | 5 | 2012 | 0 | ||
1024069417 | 10240694 | 6 | 20120524 | 0 | ||
1024069417 | 10240694 | 7 | 20130524 | 201508 | 0 | |
1024069417 | 10240694 | 8 | 20150901 | 0 |